Skip to the page

Data / Crowdfunding / Texas / Bioclonetics Immunotherapeutics, Inc.

Bioclonetics Immunotherapeutics, Inc.: crowdfunding raise on StartEngine Capital, LLC, $10,000 to $683,234 (2018)

Bioclonetics Immunotherapeutics, Inc., a corporation in Heath, TX, filed a Form C with the SEC on August 28, 2018 to raise $10,000 to $683,234 in Convertible Note through StartEngine Capital, LLC. The offering closed on November 2, 2018. In its most recent fiscal year it reported $0 in revenue and a net loss of $80,591, with 3 employees.

SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.

Website
www.bioclonetics.com
Funding portal
StartEngine Capital, LLC
Address
1756 BISON MEADOW LANE, Heath, TX 75032
Legal form
Corporation
Jurisdiction
TX
Incorporated
December 24, 2009
SEC CIK
0001701251

Offering terms

From the amendment filed August 28, 2018.

Security
Convertible Note
Price
$1.00
Target
$10,000
Maximum
$683,234
Deadline
November 2, 2018
Portal compensation
6 percent

Financials

From the Form C-U filed May 8, 2019.

Most recent fiscal yearPrior fiscal yearSource
Revenue$0$0sec.gov
Cost of goods sold$0$0sec.gov
Net income$-80,591$-40,774sec.gov
Taxes paid$0$0sec.gov
Total assets$1,195$226sec.gov
Cash$1,195$226sec.gov
Accounts receivable$0$0sec.gov
Short-term debt$0$0sec.gov
Long-term debt$0$0sec.gov

Filings

FiledFilingTargetMaximumDeadlineNoteSource
May 8, 2019Progress update$200,000$1,000,000September 29, 2017The amount raised at the time of closing is $255,600.sec.gov
May 2, 2019Annual report, amendedNot listedNot listedsec.gov
May 2, 2019Annual reportNot listedNot listedsec.gov
November 6, 2018Progress update$10,000$683,234November 2, 2018The amount raised at the time of closing is $265,800.sec.gov
August 28, 2018Amendment$10,000$683,234November 2, 2018Issuer is extending their campaign.sec.gov
June 28, 2018Amendment$10,000$683,234September 3, 2018Issuer is extending their campaign, raising their maximum funding goal, and updating their financials.sec.gov
May 25, 2018Annual reportNot listedNot listedsec.gov
April 27, 2018Amendment$10,000$148,234July 2, 2018Issuer is extending their campaign and updating their financials.sec.gov
April 4, 2018Amendment$10,000$148,234April 30, 2018Update to offering document due to xml filing error.sec.gov
March 27, 2018Amendment$10,000$148,234April 30, 2018Issuer is extending, adjusting their minimum purchase price, and updating the terms of their offering.sec.gov
January 5, 2018Offering$10,000$148,234April 4, 2018sec.gov
December 4, 2017Progress update$200,000$1,000,000September 29, 2017The final number is $386,766.00 in investments.sec.gov
November 7, 2017Progress update$200,000$1,000,000September 29, 2017$415,214.00 in investments. Payments are still being processed; final number is yet to be determined.sec.gov
September 1, 2017Amendment$200,000$1,000,000October 8, 2017Personnel changes, updated disclosures regarding Dr. Joseph Cotropia medical license being revoked, and updated business plan.sec.gov
April 11, 2017Offering$200,000$1,000,000October 8, 2017sec.gov

All filings on sec.gov

Updated May 8, 2019. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.